Elemene injection induced autophagy protects human hepatoma cancer cells from starvation and undergoing apoptosis

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Lin, Yan ^a,b   Wang, Keming ^b   Hu, Chunping ^c   Lin, Lin ^c   Qin, Shukui ^d   Cai, Xueting ^c  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c Jiangsu Province Institute of Traditional Chinese Medicine   (China)

^d 81 Hospital of PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APATINIB; BETA ELEMENE; CASPASE 3; CASPASE 9; HYDROXYCHLOROQUINE; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN LC3 I; PROTEIN LC3 II; PROTEIN LC3 III; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CARCINOMA CELL; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL CARCINOMA; LYSOSOME; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84934937171     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/637528     Document Type: Article

References (22)

1. J. M. Llovet, A. Burroughs, and J. Bruix, "Hepatocellular carcinoma, " The Lancet, vol. 362, no. 9399, pp. 1907-1917, 2003.
2. M. Hidalgo and S. G. Eckhardt, "Development of matrix metalloproteinase inhibitors in cancer therapy, " Journal of the National Cancer Institute, vol. 93, pp. 178-193, 2001.
3. D. L. Vaux, "A boom time for necrobiology, " Current Biology, vol. 3, pp. 877-878, 1993.
4. K. Wang, X. Yin, D.T. Chao, C. L. Milliman, and S. J. Korsmeyer, "BID: A novel BH3 domain-only death agonist, " Genes and Development, vol. 10, no. 22, pp. 2859-2869, 1996.
5. I. Tanida, "Autophagosome formation and molecular mechanism of auto phagy, " Antioxidants and Redox Signaling, vol. 14, no. 11, pp. 2201-2214, 2011.
6. J. Li, X. Zhao, L. Chen et al., "Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor- 2 inhibitor YN968D1 in patients with advanced malignancies, " BMC Cancer, vol. 10, article 529, 2010.
7. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, "Global cancer statistics, " CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69-90, 2011.
8. J. F. Perz, G. L. Armstrong, L. A. Farrington, Y. J. F. Hutin, and B. P. Bell, "The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide, " Journal of Hepatology, vol. 45, no. 4, pp. 529-538, 2006.
9. Z. Y. Tang, "Hepatocellular carcinoma surgery-review of the past and prospects for the 21st century, " Journal of Surgical Oncology, vol. 91, pp. 95-96, 2005.
10. E.H. Park, Y. J. Kim, N. Yamabe et al., "Stereospecific anticancer effects of ginsenoside Rg3 epimers isolated from heat-processed American ginseng on human gastric cancer cell, " Journal of Ginseng Research, vol. 38, no. 1, pp. 22-27, 2014.
11. S. I. Jang, Y.W. Lee, C. K. Cho, H. S. Yoo, and J. H. Jang, "Identification of target genes involved in the antiproliferative effect of enzyme-modified ginseng extract in HepG2 hepatocarcinoma cell, " Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 502568, 8 pages, 2013.
12. X. Chen, Y.Wang, H.Luo et al., "B-elemene acts as an antitumor factor and downregulates the expression of survivin, Bcl-xL and Mta-1, " Molecular Medicine Reports, vol. 6, no. 5, pp. 989-995, 2012.
13. X. Lu, Y.Wang, H. Luo et al., "B-elemene inhibits the proliferation of T24 bladder carcinoma cells through upregulation of the expression of Smad4, " Molecular Medicine Reports, vol. 7, no. 2, pp. 513-518, 2013.
14. H. Shi, L. Liu, J. Geng, Y. Zhou, and L. Chen, "beta-Elemene inhibits the metastasis of B16F10 melanoma cells by down regulation of the expression of uPA, uPAR, MMP-2, and MMP-9, " Melanoma Research, vol. 24, pp. 99-107, 2014.
15. H. Q. Hua, S. K. Qin, J. H. Wang, and H. Chen, "Study on effect of arsenic trioxide on adhesion and invasion of human hepatocarcinoma cells in vitro, " Chinese journal of integrated traditional and Western medicine, vol. 24, no. 10, pp. 922-925, 2004.
16. N. Y. Lin, C. Beyer, A. Gießl et al., "Autophagy regulates TNFa- mediated joint destruction in experimental arthritis, " Annals of the Rheumatic Diseases, vol. 72, no. 5, pp. 761-768, 2013.
17. K. S. Choi, "Autophagy and cancer, " Experimental & Molecular Medicine, vol. 44, pp. 109-120, 2012.
18. R. Mathew, C. M. Karp, B. Beaudoin et al., "Autophagy suppresses tumorigenesis through elimination of p62, " Cell, vol. 137, pp. 1062-1075, 2009.
19. A. Herman-Antosiewicz, D. E. Johnson, and S. V. Singh, "Sulforaphane causes autophagy to inhibit release of cytochrome c and apoptosis in human prostate cancer cells, " Cancer Research, vol. 66, no. 11, pp. 5828-5835, 2006.
20. C. Ji, L. Zhang, Y. Cheng et al., "Induction of autophagy contributes to crizotinib resistance in ALK-positive lung cancer, " Cancer Biology &Therapy, vol. 15, no. 5, pp. 570-577, 2014.
21. J.Wang and G. S.Wu, "Role of autophagy in cisplatin resistance in ovarian cancer cells, " The Journal of Biological Chemistry, vol. 289, no. 24, pp. 17163-17173, 2014.
22. M. K. Sannigrahi, V. Singh, R. Sharma, N. K. Panda, and M. Khullar, "Role of autophagy in head and neck cancer and therapeutic resistance, " Oral Diseases, 2014.